A new study from Oregon Health & Science University is the first to suggest that binaural pitch fusion—a process that ...

Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Cochlear (ASX: COH) shares are trading at the lowest level since December 2023 after the company reported a ...